Identification

Namebifidobacterium breve M-16V

Regulatory

FDA/DG SANTE Petitions, Reviews, NoticesGRN 455

Physical Properties

Food Chemicals Codex Listed No

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryfood additive
Recommendation for bifidobacterium breve M-16V usage levels up tonot for fragrance use.
Recommendation for bifidobacterium breve M-16V flavor usage levels up tonot for flavor use.

Chemical sources Association Inc

Exchange of knowledge

Need This Item for Flavor? You can contact the Chemical Sources Association.

Potential Uses

None Found

Natural Occurrence

bifidobacterium breve PMC

Synonyms

bifidobacterium breve M-16V PubMed: The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V. PubMed: Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial. PubMed: No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. PubMed: Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats. PubMed: Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model. PubMed: Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants. PubMed: Novel immunotherapy approaches to food allergy. PubMed: Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. PubMed: Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans. PubMed: Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration. PubMed: Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides. PubMed: Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine. PubMed: Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. PubMed: Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. PubMed: Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. PubMed: Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. PubMed: Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. PubMed: Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. PubMed: Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. PubMed: [Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis]. PubMed: Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.